Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Management of Secondary Progressive Multiple Sclerosis: Prophylactic Treatment-Past, Present, and Future Aspects.
Cerebrospinal fluid aquaporin-4 antibody levels in neuromyelitis optica attacks.
Update on neurodegeneration with brain iron accumulation.
The Lateral Membrane Organization and Dynamics of Myelin Proteins PLP and MBP Are Dictated by Distinct Galactolipids and the Extracellular Matrix.
Recommendations from the National Multiple Sclerosis Society Clinical Outcomes Assessment Task Force.
Spousal support as experienced by people with multiple sclerosis: a qualitative study.
Optical Coherence Tomography versus Visual Evoked Potentials in detecting subclinical visual impairment in multiple sclerosis.
Early cerebrovascular inflammation in a transgenic mouse model of Alzheimer's disease.
Central nervous system demyelinating disease-associated uveitis.
Astrocyte loss and astrogliosis in neuroinflammatory disorders.
Mode of proviral activation of a putative mammary oncogene (int-1) on mouse chromosome 15.
The multiple sclerosis depression rating scale.
Predictors of Conversion to Multiple Sclerosis in Patients with Clinical Isolated Syndrome Using the 2010 Revised McDonald Criteria.
Pediatric Multiple Sclerosis with Primary Progressive Course-Report of a Retrospective Cohort Study in Iran.
Guillain-Barre syndrome masquerading as acute respiratory failure in an infant.
An unusual case of recurrent Guillain-Barré syndrome with normal cerebrospinal fluid protein levels: a case report.
The Effect of Contralateral Strength Training on Muscle Weakness in People With Multiple Sclerosis: A Proof-of-Concept Case Series.
Multiple Sclerosis: Risk Factors and Their Interactions.
[The neurodegenerative process in multiple sclerosis and the possible neuroprotective effect of treatment with Β-interferon 1a (avonex).]
Nabiximols (THC/CBD Oromucosal Spray, Sativex®) in Clinical Practice - Results of a Multicenter, Non-Interventional Study (MOVE 2) in Patients with Multiple Sclerosis Spasticity.
Development of a selective S1P1 receptor agonist, Syl930, as a potential therapeutic agent for autoimmune encephalitis.
Statin treatment of adult human glial progenitors induces PPAR gamma-mediated oligodendrocytic differentiation.
Characteristics influencing therapy switch behavior after suboptimal response to first-line treatment in patients with multiple sclerosis.
Experience with Fingolimod in Clinical Practice.
Long-term daily vibration exposure alters current perception threshold (CPT) sensitivity and myelinated axons in a rat-tail model of vibration-induced injury.

Pages